Helius’ new subsidiary, Revelation Neuro, will target a non-implantable form of BCI. Helius Medical Technologies is muscling ...

Eye cancer is rare, accounting for less than 1% of all new cancer cases in the UK. Image credit: Leonardo Gabriel Tallone via ...

University of Turku researchers have developed sensors from single-wall carbon nanotubes for continuous health monitoring.

The FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.